What is Cardionomic?
Cardionomic is dedicated to revolutionizing the treatment of Acute Decompensated Heart Failure (ADHF) through the development of advanced medical devices. The company is actively involved in clinical studies to validate its evidence-based solutions, which are designed for healthcare providers and institutions managing heart failure patients. Operating under investigational device regulations in the United States, Cardionomic's work is crucial for advancing patient care in a critical medical field. The company's focus on innovative technology positions it as a key player in the medical technology landscape.
How much funding has Cardionomic raised?
Cardionomic has raised a total of $21.8M across 1 funding round:
Series A
$21.8M
Series A (2015): $21.8M with participation from New Enterprise Associates, Greatbatch Inc., and The Cleveland Clinic
Key Investors in Cardionomic
New Enterprise Associates
New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, known for its focus on empowering entrepreneurs and building impactful businesses across various sectors.
Greatbatch Inc.
Greatbatch Inc., now part of Integer Holdings Corporation, is a leading medical device outsource manufacturer specializing in cardiac, neuromodulation, and vascular markets, providing innovative technologies and manufacturing solutions.
The Cleveland Clinic
The Cleveland Clinic is a world-renowned non-profit academic medical center and hospital based in Cleveland, Ohio, recognized for its clinical excellence and medical research.
What's next for Cardionomic?
With a substantial funding history, Cardionomic is poised for significant expansion and further clinical validation. The recent major strategic investment suggests a strong confidence from backers in the company's technology and market potential. Future endeavors will likely involve scaling manufacturing, broadening clinical adoption, and potentially pursuing further regulatory approvals. This capital infusion is expected to accelerate the company's mission to transform ADHF treatment, solidifying its position in the competitive medical device market.
See full Cardionomic company page
